Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Paion Ag's share price for the quarter that ended in Jun. 2023 was €18.36. Paion Ag's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 7.13 Mil. Therefore, Paion Ag's market cap for the quarter that ended in Jun. 2023 was €130.97 Mil.
Paion Ag's quarterly market cap
stayed the same
from Jun. 2022 (€130.97 Mil) to Dec. 2022 (€130.97 Mil) and
stayed the same
from Dec. 2022 (€130.97 Mil) to Jun. 2023 (€130.97 Mil).
Paion Ag's annual market cap
declined
from Dec. 2020 (€162.49 Mil) to Dec. 2021 (€130.97 Mil) but then
stayed the same
from Dec. 2021 (€130.97 Mil) to Dec. 2022 (€130.97 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Paion Ag's Enterprise Value for Today is €16.83 Mil.
Paion Ag Market Cap Historical Data
The historical data trend for Paion Ag's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paion Ag's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Market Cap distribution charts can be found below:
* The bar in red indicates where Paion Ag's Market Cap falls into.
Paion Ag Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Paion Ag's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paion Ag (LTS:0NF3) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Paion Ag Market Cap Related Terms
Thank you for viewing the detailed overview of Paion Ag's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0NF3 has been successfully added to your 